| mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.05 |
| mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
0.28 |
0.05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |